Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 4/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16877179 | 0.70 | ACHE (0.35) | ACHETDP1MAOBMAOAIDO1 | |
| SCHEMBL19033437 | 0.69 | ACHE (0.44) | ACHETDP1ELANEMAOBMAOA | |
| P-Xylene SCHEMBL28101792 | 0.67 | — | — | |
| SCHEMBL4594159 | 0.65 | ACHE (0.35) | ACHETDP1MAPTMAOBMAOA | |
| P-Xylene SCHEMBL28331001 | 0.65 | ACHE (0.67) | ACHETDP1MAPTIDO1CA1 | |
| P-Xylene SCHEMBL28336749 | 0.64 | ACHE (0.80) | ACHETDP1IDO1CA1CA2 | |
| P-Xylene SCHEMBL460348 | 0.63 | ACHE (1.00) | ACHETDP1IDO1CA1CA2 | |
| P-Xylene SCHEMBL11770184 | 0.63 | ACHE (1.00) | ACHETDP1IDO1CA1CA2 | |
| P-Xylene SCHEMBL771 | 0.63 | — | — | |
| P-Xylene SCHEMBL11772917 | 0.63 | ACHE (1.00) | ACHETDP1IDO1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019143833-A1 | COMPOUNDS FOR TREATING RAC-GTPASE MEDIATED DISORDER | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2019-07-25 | — | — | WO | disclosed |